Am J Transplant, Volume 22, Suppl 3 Archives - Page 96 of 190 - ATC Abstracts

2022 American Transplant Congress
Experience with Covid-19 Infection and Vaccination in Combined Kidney/HSCT Recipients
M. Gibson¹, D. Belshe¹, G. Gregory¹, S. Tanna¹, M. Ison¹, S. Ildstad², J. R. Leventhal¹
¹Northwestern University, Chicago, IL, ²University of Louisville, Louisville, KY
*Purpose: Kidney transplant(KTx) recipients are at increased risk of COVID-19 related complications. KTx pts who have undergone therapy to induce tolerance are a unique cohort…
2022 American Transplant Congress
Gm2a Regulates Memory Cd8⁺ T Cell Activation and Differentiation
K. P. Tong¹, K. M. Baecher², C. R. Hartigan¹, M. Ford³
¹Emory University Transplant Center, Emory University, Atlanta, GA, ²Department of Surgery, Emory University, Atlanta, GA, ³Emory University, Atlanta, GA
*Purpose: In a clinical trial, patients who underwent kidney transplantation and were subsequently stable off tacrolimus immunosuppression exhibited increased Gm2a transcript in PBMC relative to…
2022 American Transplant Congress
Ethnic Variation in Adult and Pediatric Liver Transplantation
N. Kemmer¹, M. Malespin¹, S. Agrawal¹, R. Syed¹, K. Alkhalloufi¹, B. Alkurdi¹, C. Albers¹, J. Buggs²
¹Tampa General Hospital, Tampa, FL, ²Transplant Surgery, Tampa General Hospital, Tampa, FL
*Purpose: Despite several policy reforms over the years, disparities in the access to solid organ transplantation continues to exist remains a significant barrier to liver…
2022 American Transplant Congress
Locoregional Therapy and Long-Term Post-Transplant Outcomes for HCC Liver Transplant Recipients
T. Ishaque, S. R. Weeks, A. Kolarich, J. Ruck, J. Garonzik-Wang, D. Segev, A. Massie, B. King
Johns Hopkins Medical Institutions, Baltimore, MD
*Purpose: In last decade, locoregional therapy (LRT) have been widely used to downstage HCC patients in order to qualify for liver transplantation. Large-scale direct comparisons…
2022 American Transplant Congress
Study of the Composition of the Inflammatory Burden on a Cohort of 125 Rejections by Multiplex Immunofluorescence
A. Mobio¹, M. Eloudzeri², L. Morin¹, J. Duong Van Huyen³, D. Anglicheau¹, M. Rabant³
¹Kidney transplantation, Necker-Enfants Malades Hospital, Paris, France, ²U1151, INEM, Paris, France, ³Pathology, Necker-Enfants Malades Hospital, Paris, France
*Purpose: The exact composition of the inflammatory burden during kidney transplant rejection has not been studied on large cohorts. Moreover, the determinants and impact of…
2022 American Transplant Congress
Validation of Donor Specific Antibody Characteristics Associated with Deleterious Outcomes: A Single Center Study of 940 Kidney Allograft Recipients
P. Lamba¹, I. Lamba¹, R. Friedlander², V. Sharma³, J. Lee², J. B. Lee⁴, C. Hartono⁵, M. Thangamani⁶, D. Sawinski², T. Salinas⁷, M. Suthanthiran⁸, D. Dadhania⁹
¹Nephrology, Hypertension and Transplantation, New York Presbyterian/Weill Cornell Medicine, New York, NY, ²New York Presbyterian/Weill Cornell Medicine, New York, NY, ³The Rogosin Inst Cornell UMC, New York, NY, ⁴Rogosin Institute, New York, NY, ⁵New York Presbyterian Hospital-Weill Cornell, New York, NY, ⁶Cornell, New York, NY, ⁷Nephrology, NY Presbyterian- Weill Cornell, New York, NY, ⁸Weill Cornell Med Ctr., New York, NY, ⁹Weill Cornell Medicine - NYPH, New York, NY
*Purpose: A reproducibility crisis is pervasive in scientific literature. We aimed to investigate whether the DSA characteristics we previously associated with antibody mediated rejection (AMR)…
2022 American Transplant Congress
The Impact of COVID-19 on Renal Function of Kidney Transplant Recipients: A Three-Month Prospective Study
R. D. Foresto¹, H. Fagundes², V. Lafico², H. Tedesco Silva Junior², M. P. Cristelli¹, J. Pestana¹
¹Hospital do Rim, Sao Paulo, Brazil, ²Hospital do Rim, Universidade Federal de São Paulo, SAo Paulo, Brazil
*Purpose: This study aimed to assess changes in renal function during the acute disease and up to three months after the onset of symptoms among…
2022 American Transplant Congress
One-Year Outcomes in Kidney Transplant Recipients with Acute Kidney Injury and COVID-19
P. Shrivastava¹, R. M. Hofmann², S. P. Norman³, D. Granger⁴, N. Khoury¹, R. Prashar¹, C. Crombez⁵, A. Patel¹, S. Nagai⁶, M. Lu⁷, M. Samaniego¹
¹Department of Medicine, Henry Ford Health System, Detroit, MI, ²Renal Associates of West Michigan, Grand Rapids, MI, ³Department of Medicine, University of Michigan, Ann Arbor, MI, ⁴Department of Surgery, Ascension St. John Hospital,, Detroit, MI, ⁵Department of Transplant Surgery, Henry Ford Health System, Detroit, MI, ⁶Department of Surgery, Henry Ford Health System, Detroit, MI, ⁷Department of Public Health Sciences, Henry Ford Health System, Detroit, MI
*Purpose: Acute kidney injury (AKI) occurs in more than half of kidney transplant recipients (KTRs) with COVID-19. The longitudinal trajectory of kidney function is unclear.…
2022 American Transplant Congress
Obinutuzumab in Kidney Transplantation: Effect on B-cell Counts and Crossmatch Tests
M. M. Nasrallah¹, M. Elalfy¹, Y. Elmesseery², I. Amer¹, P. Malvezzi³, L. Rostaing⁴
¹Misr International Hospital, Cairo, Egypt, ²Misr International Hospital, Caire, Egypt, ³CHU Grenoble-Alpes, Grenoble, France, ⁴Service de Néphrologie, CHU Grenoble-Alpes, Grenoble, France
*Purpose: Resistance to the action of rituximab (RTX), has been documented in several diseases. More recently, obinutuzumab (OBZ) has shown promise where RTX has failed…
2022 American Transplant Congress
Simultaneous Liver-Kidney Transplantation is Accompanied by Significant Return of Native Renal Function as Demonstrated by Mag3 Scan
G. Werneburg, D. Goldfarb, R. Fatica, E. Poggio, Y. Lin, M. Eltemamy, A. Wee
Cleveland Clinic, Cleveland, OH
*Purpose: Simultaneous liver-kidney transplant (SLK) has become an increasingly popular option due to commonly comorbid renal insufficiency in liver failure,. Following SLK, it is unknown…